Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 7Unknown 2Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Breast 2Thoracic 1

Conditions

Breast Neoplasms 2Inflammation 1

Interventions

Cyclophosphamide 89Capecitabine 88Trastuzumab 81Docetaxel 81Paclitaxel 65Epirubicin 57pyrotinib 55Tamoxifen 54Letrozole 53Fulvestrant 49Vinorelbine 43Carboplatin 43Doxorubicin 41Radiotherapy 33Anastrozole 32exemestane 31Neoadjuvant Therapy 29palbociclib 27Drug Therapy 27Fluorouracil 24Bevacizumab 24pertuzumab 23Cisplatin 23eribulin 22Exercise 21130-nm albumin-bound paclitaxel 21Goserelin 20Gemcitabine 20Chemotherapy, Adjuvant 19Albumin-Bound Paclitaxel 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Fish Oils × Breast × Clear all
NCT03516253 2022-11-03

Fish Oil and EPO in Breast Cancer

University of Belgrade

Phase NA Unknown
60 enrolled
Breast

Breast Neoplasms

NCT01049295 2011-11-01

Omega-3 Fatty Acids and Chemotherapy-induced Neuropathy and Inflammation in Breast Cancer

Tehran University of Medical Sciences

Phase 4 Unknown
52 enrolled
Breast

Breast Neoplasms, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡